Skip to main content

Screening, Survival and Mortality for Cervical Cancer

Buy Article:

$24.00 plus tax (Refund Policy)

Cervical cancer is largely preventable. Screening by regular pelvic exam and pap smears can identify premalignant lesions, which can be effectively treated before the occurrence of the cancer. Regular screening also increases the probability of diagnosing early stages of the cancer and improving survival. Consequently, the Council of the European Union and the European Commission promote population based cancer screening programmes among member states (European Union, 2003; European Commission, 2008c) and European countries have instituted screening programmes with specific periodicity and target groups. In addition, promising cancer preventing vaccines have been developed based on the discovery that cervical cancer is caused by sexual transmission of certain forms of the Human Papilloma Virus. The efficacy and safety of those vaccines is now well established, but debates about cost‐effectiveness and the implications of vaccination programmes for teenagers for a sexually transmitted disease continue in a number of countries (Huang, 2008).
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Document Type: Review Article

Publication date: 2010-12-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more